Latest Eloxx Pharmaceuticals News & Updates

See the latest news and media coverage for Eloxx. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Eloxx Pharmaceuticals (Eloxx)

Clinical-stage biotech developing investigational treatments for rare kidney diseases

eloxxpharma.com
Headquarters
Watertown, United States
Founded year
2013
Company type
Public company
Number of employees
15–50
Industry
Pharmaceuticals

Last updated

Latest news about Eloxx Pharmaceuticals (Eloxx)

In short: Eloxx published Phase 2a Alport data, advanced its ADPKD trial and began dosing its Phase 2b Alport study.

Company announcements

Eloxx

Eloxx prices $66 million public offering and uplists to Nasdaq

It offers 2,975,000 shares at $11.00 and pre-funded warrants for 3,025,000 shares at $10.99, with trading on the Nasdaq Capital Market expected June 9.

Unlock all announcements with a

Media coverage

Finanznachrichten

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

ARLINGTON, Mass., June 8, 2026 /PRNewswire/ -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) ("Eloxx" and the "Company"), a clinical-stage biopharmaceutical company developing novel, small molecule product...

Unlock all articles with a

Never miss news about Eloxx

Track Eloxx and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.